HSAN-2B

RETREG1 | 2009

What Is HSAN-2B?

HSAN-2B is a type of CMT caused by autosomal recessive mutations in the RETREG1 gene. This gene provides instructions for making a protein involved in the recycling of cellular membranes within sensory nerve cells. Mutations in the RETREG1 gene disrupt this function, leading to impaired nerve signal transmission.

HSAN-2B is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

The age of symptom onset in HSAN-2B is variable, ranging from childhood to adulthood. The disease involves loss of sensation that begins in the hands and feet (glove-and-stocking distribution) and progresses over time towards the center of the body. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

HSAN-2B symptoms may include:

  • Progressive loss of sensation in the feet and hands
  • Loss of pain and temperature sensation
  • Autonomic features, including excessive sweating and urinary incontinence
  • Reduced or absent reflexes
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Distal weakness that develops as the disease progresses
  • Foot drop
  • Additional symptoms not listed here

Disease Course

HSAN-2B shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
HSAN-2B

Classification
HSAN

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
RETREG1

Gene Full Name
reticulophagy regulator 1

HGNC Gene Alias(es)
FAM134B

Chromosome
5p15.1

Zygosity of Responsible Variant
Homozygous

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Complete loss

Confidence:
High

Prediction:
Loss of an ER-phagy receptor is what the literature predicts for HSAN-2B: recessive nonsense and frameshift alleles in RETREG1 (FAM134B) remove the reticulophagy receptor that shapes endoplasmic reticulum membranes and delivers ER fragments to autophagic turnover. Sensory neurons, with their long axons and heavy secretory load, degenerate once both copies are inactivated, and supplying the intact receptor is predicted to restore ER turnover.

Rationale:
The alleles are truncating and the phenotype needs two of them, which is the signature of a missing receptor rather than a mutant one acting on its partners. RETREG1 depletion impairs ER membrane remodeling and reticulophagy in cell models, tying the genetic pattern to a defined cell-biological deficit in long sensory axons.

ClinVar Pathogenic Variants

View RETREG1 ClinVar Variants

HSAN-2B OMIM Entry

HSAN-2B OMIM

RETREG1 OMIM Entry

RETREG1 OMIM

More Info

HSAN-2B Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Mutations in FAM134B, Encoding a Newly Identified Golgi Protein, Cause Severe Sensory and Autonomic Neuropathy

Authors

Kurth, I., Pamminger, T., Hennings, J. C., Soehendra, D., Huebner, A. K., Rotthier, A., Baets, J., Senderek, J., Topaloglu, H., Farrell, S. A., Nürnberg, G., Nürnberg, P., De Jonghe, P., Gal, A., Kaether, C., Timmerman, V., & Hübner, C. A.

Publication Date
October 18, 2009

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.